Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Rempel, Gina
and
Coates, Jan
1999.
Special Considerations for Medication Use in Children with Developmental Disabilities.
Physical Medicine and Rehabilitation Clinics of North America,
Vol. 10,
Issue. 2,
p.
493.
Khan, Adil
Faught, Edward
Gilliam, Frank
and
Kuzniecky, Ruben
1999.
Acute psychotic symptoms induced by topiramate.
Seizure,
Vol. 8,
Issue. 4,
p.
235.
Jackson, Michael F.
Esplin, Barbara
and
Čapek, Radan
2000.
Reversal of the activity-dependent suppression of GABA-mediated inhibition in hippocampal slices from γ-vinyl GABA (vigabatrin)-pretreated rats.
Neuropharmacology,
Vol. 39,
Issue. 1,
p.
65.
Bello‐Ramírez, Angélica M.
Carreón‐Garabito, Blanca Y.
and
Nava‐Ocampo, Alejandro A.
2002.
Do Structural Properties Explain the Anticonvulsant Activity of Valproate Metabolites? A QSAR Analysis.
Epilepsia,
Vol. 43,
Issue. 5,
p.
475.
Trackman, P. C.
and
Kantarci, A.
2004.
Connective Tissue Metabolism and Gingival Overgrowth.
Critical Reviews in Oral Biology & Medicine,
Vol. 15,
Issue. 3,
p.
165.
Moura, Lidia M.V.R.
Donahue, Maria A.
Yan, Zhiyu
Smith, Louisa H.
Hsu, John
Newhouse, Joseph P.
Schwamm, Lee H.
Haneuse, Sebastien
Hernandez-Diaz, Sonia
and
Blacker, Deborah
2023.
Comparative Effectiveness and Safety of Seizure Prophylaxis Among Adults After Acute Ischemic Stroke.
Stroke,
Vol. 54,
Issue. 2,
p.
527.